Histone H3 and Its Role in Disease and Therapeutic Applications

Histone H3 and Its Role in Disease and Therapeutic Applications

Histone H3 is a key player in the regulation of gene expression and has been implicated in various diseases, including cancer. Histone H3 has four isoforms, H3-伪, H3-尾, H3-纬, and H3-m, which differ in their size and composition. H3-7, also known as pseudogene 2, is one of the smaller isoforms of histone H3 and is expressed in a variety of tissues, including muscle, heart, and brain.

H3-7 has been shown to play a crucial role in the regulation of gene expression and has been implicated in various diseases, including cancer. Studies have shown that H3-7 can interact with various transcription factors, including nuclear factor E2 (NF-E2), to regulate the expression of target genes. H3-7 has also been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.

One of the main advantages of H3-7 is its small size, which makes it a potential drug target. H3-7 can be targeted using small molecules, such as inhibitors of the interaction between H3-7 and transcription factors, or by modifying the structure of H3-7 itself. Additionally, because H3-7 is expressed in a variety of tissues, it is a potential biomarker for various diseases.

H3-7 has also been shown to play a role in the regulation of cancer progression. Studies have shown that H3-7 levels are elevated in various types of cancer and that it can contribute to the development and progression of these diseases. For example, H3-7 has been shown to be upregulated in breast cancer and has been linked to the development of resistance to chemotherapy.

In addition to its potential as a drug target and biomarker, H3-7 is also of interest to researchers as a potential therapeutic agent. Studies have shown that H3-7 can be downregulated by small molecules and that this downregulation can lead to the inhibition of various cellular processes, including cell growth and apoptosis. This suggests that H3-7 could be an effective therapeutic agent for a variety of diseases, including cancer.

In conclusion, H3-7 is a small isoform of histone H3 that has been shown to play a crucial role in the regulation of gene expression and the regulation of cellular processes. Its small size makes it a potential drug target and it has been implicated in various diseases, including cancer. Additionally, H3-7 has also been shown to be a potential therapeutic agent and its properties make it a promising target for the development of new treatments for a variety of diseases. Further research is needed to fully understand the role of H3-7 in the regulation of gene expression and its potential as a therapeutic agent.

Protein Name: H3.7 Histone (putative)

Functions: Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling

The "H3-7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about H3-7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

H3C1 | H3C10 | H3C11 | H3C12 | H3C13 | H3C14 | H3C15 | H3C2 | H3C3 | H3C4 | H3C6 | H3C7 | H3C8 | H3P16 | H3P36 | H3P37 | H3P44 | H3P5 | H3P6 | H4C1 | H4C11 | H4C12 | H4C13 | H4C14 | H4C15 | H4C16 | H4C2 | H4C3 | H4C4 | H4C5 | H4C6 | H4C7 | H4C8 | H4C9 | H6PD | HAAO | HABP2 | HABP4 | HACD1 | HACD2 | HACD3 | HACD4 | HACE1 | HACL1 | HADH | HADHA | HADHAP1 | HADHB | HAFML | HAGH | HAGHL | HAGLR | HAGLROS | HAL | HAMP | HAND1 | HAND2 | HAND2-AS1 | HAO1 | HAO2 | HAO2-IT1 | HAP1 | HAPLN1 | HAPLN2 | HAPLN3 | HAPLN4 | HAPSTR1 | HAR1A | HAR1B | HARBI1 | HARS1 | HARS2 | HAS1 | HAS2 | HAS2-AS1 | HAS3 | HASPIN | HAT1 | HAUS1 | HAUS1P1 | HAUS2 | HAUS3 | HAUS4 | HAUS5 | HAUS6 | HAUS7 | HAUS8 | HAVCR1 | HAVCR1P1 | HAVCR2 | HAX1 | HAX1P1 | HBA1 | HBA2 | HBAP1 | HBB | HBBP1 | HBD | HBE1 | HBEGF